Guidelines

US Preventive Services Task Force lowers diabetes screening age for overweight


 

FROM JAMA

ADA recommendations differ

The new recommendations differ from American Diabetes Association guidelines, which call for diabetes screening at all ages for people who are overweight or obese and who have one or more risk factors, such as physical inactivity or a first-degree relative with diabetes. If results are normal, repeat screening at least every 3 years is recommended.

The ADA further recommends universal screening for all adults 45 years and older, regardless of their risk factors.

For the screening of adults over 45, the ADA recommends using a fasting plasma glucose level, 2-hour plasma glucose level during a 75-g oral glucose tolerance test, or A1c level, regardless of risk factors.

The American Association of Clinical Endocrinology also recommends universal screening for prediabetes and diabetes for all adults 45 years or older, regardless of risk factors, and also advises screening those who have risk factors for diabetes regardless of age.

Screening of little benefit without behavior change support

In an interview, Dr. Grant added that broad efforts are essential as those at the practice level have clearly not succeeded.

Dr. Richard W. Grant

Dr. Richard W. Grant

“The medical model of individual counseling and referral has not really been effective, and so we really need to think in terms of large-scale public health action,” said Dr. Grant, of the division of research, Kaiser Permanente Northern California, Oakland.

His editorial details the sweeping, multifactorial efforts that are needed.

“To turn this recommendation into action – that is, to translate screening activities into improved clinical outcomes – change is needed at the patient-clinician level (recognizing and encouraging eligible individuals to be screened), health care system level (reducing screening barriers and ensuring access to robust lifestyle programs), and societal level (applying effective public health interventions to reduce obesity and increase exercise),” they write.

A top priority has to be a focus on individuals of diverse backgrounds and issues such as access to healthy programs in minority communities, Dr. Grant noted.

“Newly diagnosed adults are more likely to be African-American and Latinx,” he said.

“We really need to invest in healthier communities for low-income, non-White communities to reverse the persistent health care disparities in these communities.”

While the challenges may appear daunting, history shows they are not necessarily insurmountable – as evidenced in the campaign to discourage tobacco smoking.

“National smoking cessation efforts are one example of a mostly successful public health campaign that has made a difference in health behaviors,” Grant noted.

The recommendation is also posted on the USPSTF web site .

Dr. Grant reports receiving grants from the National Institutes of Health and the Patient-Centered Outcomes Research Institute.

Pages

Recommended Reading

FDA clears app for FreeStyle Libre 2 glucose monitor
Journal of Clinical Outcomes Management
Patients with diabetes more likely to be hospitalized, especially with foot infection
Journal of Clinical Outcomes Management
Tackle obesity to drop risk for secondary cardiac event
Journal of Clinical Outcomes Management
Task force affirms routine gestational diabetes testing
Journal of Clinical Outcomes Management
Recent Trends in Diabetes Treatment and Control in US Adults: A Geriatrician’s Point of View
Journal of Clinical Outcomes Management
Obesity leads to depression via social and metabolic factors
Journal of Clinical Outcomes Management
Low glycemic diet improves A1c, other risk factors in diabetes
Journal of Clinical Outcomes Management
FDA approves rapid-acting insulin, Lyumjev, for pump use
Journal of Clinical Outcomes Management
Pandemic derails small success in lowering diabetes-related amputations
Journal of Clinical Outcomes Management
Empagliflozin gets HFrEF approval from FDA
Journal of Clinical Outcomes Management